DENTSPLY International (XRAY) : Hills Bank Trust Co reduced its stake in DENTSPLY International by 2.64% during the most recent quarter end. The investment management company now holds a total of 33,104 shares of DENTSPLY International which is valued at $1,979,288 after selling 898 shares in DENTSPLY International , the firm said in a disclosure report filed with the SEC on Oct 11, 2016.DENTSPLY International makes up approximately 0.72% of Hills Bank Trust Co’s portfolio.
Other Hedge Funds, Including , Cobiz Investment Management boosted its stake in XRAY in the latest quarter, The investment management firm added 122 additional shares and now holds a total of 59,267 shares of DENTSPLY International which is valued at $3,543,574. DENTSPLY International makes up approx 0.86% of Cobiz Investment Management’s portfolio.Independent Portfolio Consultants reduced its stake in XRAY by selling 675 shares or 18.29% in the most recent quarter. The Hedge Fund company now holds 3,015 shares of XRAY which is valued at $177,704. DENTSPLY International makes up approx 0.06% of Independent Portfolio Consultants’s portfolio.Chevy Chase Trust Holdings reduced its stake in XRAY by selling 6,452 shares or 3.11% in the most recent quarter. The Hedge Fund company now holds 200,921 shares of XRAY which is valued at $11,842,284. DENTSPLY International makes up approx 0.07% of Chevy Chase Trust Holdings’s portfolio.Washington Trust Bank reduced its stake in XRAY by selling 45 shares or 66.18% in the most recent quarter. The Hedge Fund company now holds 23 shares of XRAY which is valued at $1,356. Harbour Capital Advisors added XRAY to its portfolio by purchasing 3,500 company shares during the most recent quarter which is valued at $206,290. DENTSPLY International makes up approx 0.11% of Harbour Capital Advisors’s portfolio.
DENTSPLY International closed down -1.9 points or -3.18% at $57.89 with 13,34,463 shares getting traded on Tuesday. Post opening the session at $59.65, the shares hit an intraday low of $57.65 and an intraday high of $59.65 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.
On the company’s financial health, DENTSPLY International reported $0.76 EPS for the quarter, beating the analyst consensus estimate by $ 0.06 according to the earnings call on Aug 5, 2016. Analyst had a consensus of $0.70. The company had revenue of $1022.00 million for the quarter, compared to analysts expectations of $1028.82 million. The company’s revenue was up 46.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.73 EPS.
Many Wall Street Analysts have commented on DENTSPLY International. DENTSPLY International was Initiated by JP Morgan to “Neutral” on Sep 22, 2016. DENTSPLY International was Downgraded by Barrington Research to ” Mkt Perform” on Aug 8, 2016.
DENTSPLY International Inc. is a designer developer manufacturer and marketer of a range of consumable dental products for the professional dental market. It operates through three segments: Dental Consumable and Certain International Businesses; Dental Specialty and Laboratory and Certain Global Distribution Businesses and Healthcare and Emerging Markets Businesses. All the segments are primarily engaged in the design manufacture and distribution of dental and medical products in four product categories. Its Dental Consumable Products consist of dental supplies and devices and small equipment used in dental offices. Its Dental Laboratory Products are used in the preparation of dental appliances by dental laboratories. Its Dental Specialty Products are specialized treatment products used within the dental office and laboratory settings. Its Consumable Medical Device Products consist mainly of urology catheters certain surgical products medical drills and other products.